233275-76-8
233275-76-8
Chemical Structure
MK-0343
Synonym(s): MRK-409
- CAS No.: 233275-76-8
- Formula:C19H17F2N7O
- Molecular Weight:397.38
IUPAC Name: 7-cyclobutyl-3-(2,6-difluorophenyl)-6-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
InChIKey: GOIFCXRIFSYPFG-UHFFFAOYSA-N
SMILES: CN1N=CN=C1COC2=NN3C(C=C2C4CCC4)=NN=C3C5=C(F)C=CC=C5F
Biological Activity: MK0343 (MRK-409) is an orally bioavailable GABAA receptor subtype-selective partial agonist. MK0343 is a non-sedating anxiolytic[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MK-0343 | 99.69% | MK0343 (MRK-409) is an orally bioavailable GABAA receptor subtype-selective partial agonist. MK0343 is a non-sedating anxiolytic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MK-0343 (Standard) | ≥98% | MK-0343 (Standard) is the analytical standard of MK-0343. This product is intended for research and analytical applications. MK0343 (MRK-409) is an orally bioavailable GABAA receptor subtype-selective partial agonist. MK0343 is a non-sedating anxiolytic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
